Therefore, instead of DNA/RNA analysis, immunohistochemical analysis with 4 markers (ER, PR, HER2, and Ki67) have been used to define subtypes of breast cancer [21, 32, 33]. This evidence concerns the gene ERBB2 and breast cancer.